4//SEC Filing
MILLENNIUM PHARMACEUTICALS INC 4
Accession 0001304930-08-000002
CIK 0001002637operating
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:16 PM ET
Size
7.8 KB
Accession
0001304930-08-000002
Insider Transaction Report
Form 4
Keating Laurie B.
SVP and General Counsel
Transactions
- Sale
Common stock
2008-01-03$16.11/sh−4,830$77,811→ 98,616 total - Sale
Common stock
2008-01-04$14.85/sh−5,281$78,423→ 93,335 total
Holdings
- 3,197(indirect: By 401(k))
Common stock
Footnotes (3)
- [F1]Pursuant to a trading plan previously established under Rule 10b5-1 of the Secutities Exchange Act of 1934, as amended, these shares were sold to cover withholding taxes on shares of restricted stock that vested on 01/01/2008.
- [F2]This transaction was effected under a trading plan previously established by the reporting person under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F3]Reflects shares allocated to the reporting person's account under Millennium's 401(k) plan as of December 31, 2007.
Documents
Issuer
MILLENNIUM PHARMACEUTICALS INC
CIK 0001002637
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001002637
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:16 PM ET
- Size
- 7.8 KB